NCT06616610

Brief Summary

The goal of this clinical trial is to determine whether the use of a mobility platform can improve response time in children with cerebral palsy. The primary question it seeks to answer is: Can the use of a mobility platform enhance cognitive development in children with severe disabilities? Children are randomly assigned to two equal-sized groups: the control group, where participants will continue with their standard therapy, and the intervention group, where participants will use the mobility platform. Researchers will compare outcomes between the two groups. Participants in the control group will engage in a traditional cause-and-effect therapy, using a video that frequently pauses, requiring them to press an adapted button to continue watching. Participants in the intervention group will use the mobility platform during their sessions. Movement begins when the participant presses the adapted button, and the platform advances, adjusting its direction using sensors to detect obstacles. Once the preset time limit is reached, the platform stops, and the child must press the button again to resume movement. This stop-start process mirrors the cause-and-effect training in the control group.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 27, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

September 20, 2024

Last Update Submit

October 10, 2024

Conditions

Keywords

Cerebral PalsyChildrenReaction Timemobility platformcognitive developmentGMFCS levels IV-Vmotor skills

Outcome Measures

Primary Outcomes (2)

  • Reaction time (RT)

    In the intervention group, RT measures the time elapsed between the platform stopping and the user pressing the button to initiate a new navigation period. In the control group, RT measures the time elapsed between the video pausing and the user pressing the button to continue watching it

    From enrollment to the end of treatment at 8 weeks

  • Number of incorrect selections (NIS)

    NIS represents the number of additional button presses recorded while the Platform is in motion and serves validation purposes. A high value of this variable, consistently maintained over time, suggests that the user is not performing the cause-effect experiment effectively.

    From enrollment to the end of treatment at 8 weeks

Secondary Outcomes (1)

  • The Self-Assessment Manikin (SAM) test

    From enrollment to the end of treatment at 8 weeks

Study Arms (2)

The Experimental Arm

EXPERIMENTAL

Participants included in arms are children with the following inclusion criteria: * Diagnosed with cerebral palsy * Classified as GMFCS level IV or higher, indicating an inability to walk or operate a powered wheelchair. * Under 12 years old. * Must be affiliated to a center whose facilities guarantee a proper navigation experience The participants will be randomly assigned to two equal-sized arms: the control arm, in which participants will continue with the traditional therapy, and the experimental arm, where the children will use the platform. The experimental arm receives an intervention (procedure) that is a focus of the study. It aims to analyze the impact of a single-button-operated mobility platform on reaction times and keypress patterns in children with severe disabilities.

Behavioral: Intervention with the Mobility Platform

The Control Arm

ACTIVE COMPARATOR

Participants included in arms are children with the following inclusion criteria: - Diagnosed with cerebral palsy - Classified as GMFCS level IV or higher, indicating an inability to walk or operate a powered wheelchair. - Under 12 years old. - Must be affiliated to a center whose facilities guarantee a proper navigation experience The participants will be randomly assigned to two equal-sized arms: the control arm, in which participants will continue with the traditional therapy, and the experimental arm, where the children will use the platform. The control arm participants continue with their regular therapy. Regular cause-effect therapies use an animated cartoon video that frequently pauses so that the children have to press an adapted button to continue watching it.

Behavioral: Intervention with Traditional Therapy

Interventions

The experimental arm receives the Intervention with Mobility Platform that is a focus of the study. It aims to analyze the impact of a single-button-operated mobility platform on reaction times and keypress patterns in children with severe disabilities.

The Experimental Arm

The traditional cause-effect therapies use an animated cartoon video that frequently pauses so that the children have to press an adapted button to continue watching it.

The Control Arm

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosed with cerebral palsy
  • Classified as GMFCS level IV or higher, indicating an inability to walk or operate a powered wheelchair.
  • Under 12 years old.
  • Must be affiliated to a center whose facilities guarantee a proper navigation experience

You may not qualify if:

  • \- Inability to act on an actuator (Start button)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Seville

Seville, Andalusia, 41010, Spain

RECRUITING

Related Links

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Methods

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Alberto Molina Cantero, PhD

    University of Seville, Seville, Andalucia, Spain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Félix Biscarri, PhD

CONTACT

Alberto Molina Cantero, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of research group

Study Record Dates

First Submitted

September 20, 2024

First Posted

September 27, 2024

Study Start

January 1, 2024

Primary Completion

January 1, 2025

Study Completion

June 1, 2025

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

IPD used in the results publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
From november 2024
Access Criteria
Everyone will be able to access all the IPD and all the supporting information. It will be available on It will be available on the Research Data Repository of the University of Seville (IdUS). IdUS is part of the digital infrastructure for open science and offers University of Seville authors a platform to deposit their publications in open access and their research data.
More information

Available IPD Datasets

Individual Participant Data Set Access

Locations